• News Feeds
Page last updated at 07:07 GMT, Friday, 24 April 2009 08:07 UK

Next stage for stem cell research

Advertisement

Pharmaceutical giant Pfizer is investing heavily in stem cell research for the first time. Reporter Angus Stickler speaks to Ruth McKernan, of Pfizer, about a therapy which could cure one of the most common forms of blindness in older people. Professor Pete Coffey, of University College London, discusses what this says about the future of stem cell research.

Story Tools

BBC navigation

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific